Skip to main content

and
  1. Article

    Open Access

    Intermittent dosing of axitinib combined with chemotherapy is supported by 18FLT-PET in gastrointestinal tumours

    We evaluated week-on/week-off axitinib dosing plus chemotherapy in patients with gastrointestinal tumours, including tumour thymidine uptake by fluorine-18 3′-deoxy-3′-fluorothymidine positron emission tomogra...

    C K Hoh, H A Burris III, J C Bendell, J Tarazi, B Rosbrook in British Journal of Cancer (2014)

  2. Article

    Open Access

    Phase I study of weekly paclitaxel in combination with pazopanib and lapatinib in advanced solid malignancies

    We assessed the maximum tolerated regimen (MTR) and dose-limiting toxicities of pazopanib and lapatinib in combination with weekly paclitaxel, and the effect of pazopanib and lapatinib on paclitaxel pharmacoki...

    A R Tan, A Dowlati, M N Stein, S F Jones, J R Infante in British Journal of Cancer (2014)